Industry Events
EnglishFrançaisEspañol中文العربية
EventsNewsInsightsOrganisers
Services
  • Event MarketingList, promote and grow your events to a global B2B audience.
  • Press ReleaseDistribute official announcements to industry professionals worldwide.
  • Speaker & SME PromotionShowcase expertise, get booked for keynotes, panels and masterclasses.
Subscribe
Speaker Sign InList Your Free Event
Industry Events

The world's most trusted B2B event discovery platform. Connecting industry professionals with the conferences, expos and summits that matter.

Explore & Services
  • Industry Events
  • News
  • Event Organisers
  • About Us
  • Our Services
  • Premium Organiser
  • Event Pro
  • Become a Speaker
  • Subscribe
Legal & Privacy
  • Terms
  • Privacy

© 2026 Industry Events Worldwide. All rights reserved.

VF103.4.
Industry Events

The world's most trusted B2B event discovery platform. Connecting industry professionals with the conferences, expos and summits that matter.

  • Industry Events
  • News
  • Event Organisers
  • About Us
  • Our Services
  • Premium Organiser
  • Event Pro
  • Become a Speaker
  • Subscribe
  • Terms
  • Privacy

© 2026 Industry Events Worldwide. All rights reserved.

VF103.4.
  • Events
  • News
  • Insights
  • Account
Industry Events
EnglishFrançaisEspañol中文العربية
EventsNewsInsightsOrganisers
Services
  • Event MarketingList, promote and grow your events to a global B2B audience.
  • Press ReleaseDistribute official announcements to industry professionals worldwide.
  • Speaker & SME PromotionShowcase expertise, get booked for keynotes, panels and masterclasses.
Subscribe
Speaker Sign InList Your Free Event
  1. Home
  2. News
  3. Cancer Drug Patent Claims Upheld by CAFC

IPWatchdog

Cancer Drug Patent Claims Upheld by CAFC

The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision on Monday in Exelixis, Inc. v. MSN Laboratories Private Ltd., affirming a district court finding that certain patent claims covering a cancer treatment satisfy the written description requirement under 35 U.S.C. Section 112(a). The court also granted a motion to dismiss a separate portion of the appeal as moot and vacated the underlying district court judgment on that issue. The post Cancer Drug Patent Claims

Continue with the complete report on the publisher’s website.

Read full article at IPWatchdog
I

By IPWatchdog

1 September 2026|1 min read
Share
Intellectual Property Law
Share
← Back to IE News

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Intellectual Property Law

  • IPWatchdog

    DOJ Sides with OpenAI, Warns Obstacles to AI Development Threaten National Security

    3 September 2026
  • IPWatchdog

    CAFC Finds Most Patent Owner Arguments Forfeited in Vitamin D Baby Drops Appeal from PTAB

    3 September 2026
  • IPWatchdog

    Other Barks & Bites for Friday, September 4: D.C. Circuit Affirms Medical Device TPM Circumvention; U.S. Earns High Ratings in IP Index Statistic Annex; and Microsoft Edge is Not Important Gatekeeper Under DMA

    4 September 2026
  • IPWatchdog

    TTI (RYOBI) is Seeking an Intellectual Property Counsel

    1 September 2026
  • Patently-O

    OED Orders from Summer 2026

    1 September 2026
  • IPWatchdog

    OpenAI Sued Over AI Patents Covering Retrieval, Personalization and Content Generation

    2 September 2026

Related Insights

  • The Bio Revolution Is Here — And the World Is Already Choosing Sides

    Biology is becoming the next great industrial platform — accelerated by AI, contested by China and the US, and creating tomorrow's careers.

    8 Sept 202613 min read
  • Quantum computing

    The race to master quantum computing could reshape medicine, energy and security.

    8 Sept 202623 min read
  • Workforce transformation and the future of skills

    10 cross-sector shifts creating the next business opportunities

    The biggest business opportunities of the next decade may not sit inside AI, energy, space, telecoms or manufacturing individually; they are emerging where growth in one sector creates a bottleneck—and therefore a market—in another.

    7 Sept 202610 min read
Browse all insights →

Related Events

  • Project Finance & Project Financial Modelling - Oct 2026

    19 Oct 2025
  • Autonomous e-Mobility Forum 2026

    7 Sept 2026
    Qatar
  • 3rd Government Digital Transformation Summit

    7 Sept 2026
    Riyadh, Saudi Arabia
  • AeroTech Vietnam 2026

    8 Sept 2026
    Hanoi, Vietnam
Browse All Events→

More From The Newsroom

  • A Patent Purchase Scam Targeting Patent Attorneys

    3 September 2026
  • Federal Circuit Affirms Judgment that Swiss Pharma Company Did Not Infringe Iron Deficiency Therapy Patent Claims

    3 September 2026
  • Hurdling Eligibility with a “Separable Interface”

    Hurdling Eligibility with a “Separable Interface”

    2 September 2026
  • SpaceTime3D Gets Mixed Results at Federal Circuit in Pair of Appeals from Apple and Google IPRs

    31 August 2026
Industry Events

The world's most trusted B2B event discovery platform. Connecting industry professionals with the conferences, expos and summits that matter.

Explore & Services
  • Industry Events
  • News
  • Event Organisers
  • About Us
  • Our Services
  • Premium Organiser
  • Event Pro
  • Become a Speaker
  • Subscribe
Legal & Privacy
  • Terms
  • Privacy

© 2026 Industry Events Worldwide. All rights reserved.

VF103.4.
Industry Events

The world's most trusted B2B event discovery platform. Connecting industry professionals with the conferences, expos and summits that matter.

  • Industry Events
  • News
  • Event Organisers
  • About Us
  • Our Services
  • Premium Organiser
  • Event Pro
  • Become a Speaker
  • Subscribe
  • Terms
  • Privacy

© 2026 Industry Events Worldwide. All rights reserved.

VF103.4.